Amyris acquires CBD beauty brand


In California, synthetic biology company Amyris has acquired cannabinoids-based beauty brand Terasana for an undisclosed sum. 

John Melo, president and CEO of Amyris said in a press statement that the company is “very optimistic” about the future of clean cannabinoids and the efficacy they bring to the skincare market. 

The company recently commercialized cannabigerol, a non-psychoactive, fermentation-based cannabinoid that when combined with the company’s biobased squalane has shown to be more effective than typical topical CBD formulations at addressing dry skin, skin flaking, irritation, and redness. “We are very pleased with the early clinical results demonstrating Amyris CBG benefits including enhanced performance when combined with squalane,” Melo adds. “During the fourth quarter of 2020 we sold out our entire first industrial production of clean CBG as an ingredient for use in flavors and fragrances.” 

Amyris’s existing clean beauty brands include Biossance skincare, Pipette baby and mother care, and Rose Inc. clean cosmetics brand. The company also recently announced a partnership with “Queer Eye” star Jonathan Van Ness.